Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5501
Cadiz
CDZI
$323M
| $94K | ﹤0.01% |
10,807
+2,606
| +32% | +$22.7K |
2013 Q2
8 quarters
|
|
5502
Orion Group Holdings
ORN
$355M
| $94K | ﹤0.01% |
13,005
+3,570
| +38% | +$29.1K |
2013 Q2
8 quarters
|
|
5503
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $94K | ﹤0.01% |
3,486
-3,007
| -46% | -$76.5K |
2013 Q2
8 quarters
|
|
|
GZT
5504
DELISTED
Gazit-globe Ltd
GZT
| $94K | ﹤0.01% |
7,932
-300
| -4% | -$3.8K |
2013 Q4
6 quarters
|
|
|
QMN
5505
DELISTED
IQ Hedge Market Neutral Tracker ETF
QMN
| $94K | ﹤0.01% |
3,699
-2,640
| -42% | -$67.3K |
2013 Q4
6 quarters
|
|
|
FXS
5506
DELISTED
Invesco CurrencyShares Swedish Krona Trust
FXS
| $94K | ﹤0.01% |
790
-46
| -6% | -$5.42K |
2013 Q2
8 quarters
|
|
|
CBD
5507
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $93K | ﹤0.01% |
3,927
-584,027
| -99% | -$17.3M |
2013 Q2
8 quarters
|
|
|
BQH
5508
DELISTED
BlackRock New York Municipal Bond Trust
BQH
| $93K | ﹤0.01% |
6,750
+3
| +0% | +$42 |
2013 Q4
6 quarters
|
|
|
SCIN
5509
DELISTED
Columbia India Small Cap ETF
SCIN
| $93K | ﹤0.01% |
6,050
+897
| +17% | +$14.8K |
2014 Q2
4 quarters
|
|
5510
Galiano Gold
GAU
$573M
| $92K | ﹤0.01% |
53,980
-5,233
| -9% | -$8.44K |
2013 Q2
8 quarters
|
|
5511
MACOM Technology Solutions
MTSI
$20.7B
| $92K | ﹤0.01% |
2,417
-5,935
| -71% | -$219K |
2013 Q2
8 quarters
|
|
|
LF
5512
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $92K | ﹤0.01% |
65,656
+10,537
| +19% | +$21.5K |
2013 Q2
8 quarters
|
|
5513
Achieve Life Sciences
ACHV
$719M
| $91K | ﹤0.01% |
18
-2
| -10% | -$9.92K |
2013 Q2
8 quarters
|
|
5514
Global X MSCI Norway ETF
NORW
$93.2M
| $91K | ﹤0.01% |
3,873
-1,209
| -24% | -$29.6K |
2013 Q2
8 quarters
|
|
5515
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $91K | ﹤0.01% |
3,502
-2,512
| -42% | -$65.7K |
2013 Q4
6 quarters
|
|
|
REN
5516
DELISTED
Resolute Energy Corporaton
REN
| $91K | ﹤0.01% |
18,981
-9,598
| -34% | -$58.4K |
2013 Q2
8 quarters
|
|
5517
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $90K | ﹤0.01% |
9,781
+2,899
| +42% | +$27.9K |
2013 Q3
7 quarters
|
|
5518
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $90K | ﹤0.01% |
89
-59
| -40% | -$63.6K |
2013 Q4
6 quarters
|
|
|
DEST
5519
DELISTED
Destination Maternity Corporation
DEST
| $90K | ﹤0.01% |
7,734
+6,106
| +375% | +$75.9K |
2013 Q2
8 quarters
|
|
|
IELG
5520
DELISTED
ISHARES ENHANCED U.S. LARGE CAP ETF
IELG
| $90K | ﹤0.01% |
2,804
| – | – |
2014 Q2
4 quarters
|
|
5521
Clarus
CLAR
$134M
| $89K | ﹤0.01% |
9,637
-10,046
| -51% | -$94.7K |
2013 Q2
8 quarters
|
|
5522
Southside Bancshares
SBSI
$909M
| $89K | ﹤0.01% |
3,286
-8,455
| -72% | -$218K |
2013 Q2
8 quarters
|
|
5523
DELISTED
Alimera Sciences
ALIM
| $89K | ﹤0.01% |
1,282
-390
| -23% | -$26.9K |
2013 Q2
8 quarters
|
|
|
NGE
5524
DELISTED
Global X MSCI Nigeria ETF
NGE
| $89K | ﹤0.01% |
2,301
+504
| +28% | +$20.4K |
2014 Q1
5 quarters
|
|
|
GSB
5525
DELISTED
GlobalSCAPE, Inc.
GSB
| $89K | ﹤0.01% |
27,260
+11,708
| +75% | +$38.3K |
2013 Q4
6 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.